Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of targeted cancer therapies. Its spirocyclic structure provides structural rigidity that enhances selectivity and binding affinity toward specific enzyme targets. Commonly employed in the optimization of drug candidates for improved metabolic stability and oral bioavailability. Also explored in the design of central nervous system agents due to its ability to cross the blood-brain barrier. The hydrochloride salt form improves solubility and handling in preclinical formulations.